Breanna Fletcher

发表

Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for ELANE Neutropenia

D. Dale, Vahagn Makaryan, Merideth L. Kelley, 2022, Journal of cellular immunology.

Elastase inhibitors as potential therapies for ELANE‐associated neutropenia

D. Dale, A. Bolyard, A. A. Aprikyan, 2017, Journal of leukocyte biology.

CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients

K. Welte, K. Hipp, Yun Xu, 2019, Haematologica.